{"id":56978,"date":"2026-07-27T17:01:25","date_gmt":"2026-07-27T23:01:25","guid":{"rendered":"https:\/\/continuamosmx.com\/?p=56978"},"modified":"2026-07-27T17:01:26","modified_gmt":"2026-07-27T23:01:26","slug":"historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias","status":"publish","type":"post","link":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/","title":{"rendered":"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS"},"content":{"rendered":"\n

*Cient\u00edficos y autoridades sanitarias japonesas dan luz verde provisional a los primeros f\u00e1rmacos basados en c\u00e9lulas madre pluripotentes inducidas (iPS), abriendo una nueva era en la medicina regenerativa mundial.<\/strong><\/h3>\n\n\n\n

TOKIO<\/strong> \u2014 En un acontecimiento considerado un hito para la ciencia m\u00e9dica moderna, Jap\u00f3n se encuentra a un paso de consolidar la comercializaci\u00f3n de los primeros tratamientos farmacol\u00f3gicos desarrollados a partir de c\u00e9lulas madre pluripotentes inducidas (c\u00e9lulas iPS). A diferencia de las c\u00e9lulas madre embrionarias, estas se obtienen directamente de tejidos adultos, lo que representa un avance \u00e9tico y t\u00e9cnico sin precedentes.<\/p>\n\n\n\n

Tratamientos innovadores para enfermedades complejas<\/h3>\n\n\n\n

El panel de expertos del Ministerio de Salud, Trabajo y Bienestar de Jap\u00f3n recomend\u00f3 otorgar la aprobaci\u00f3n provisional a dos medicamentos pioneros en su tipo:<\/p>\n\n\n\n

    \n
  • Amshepri:<\/strong> Dise\u00f1ado espec\u00edficamente para pacientes que padecen la enfermedad de Parkinson, buscando frenar el deterioro neurol\u00f3gico y mejorar la calidad de vida de quienes lo sufren.<\/li>\n\n\n\n
  • Reheart:<\/strong> Indicado para el tratamiento de la miocardiopat\u00eda isqu\u00e9mica, una afecci\u00f3n donde el m\u00fasculo card\u00edaco pierde fuerza y funcionalidad debido a una deficiencia cr\u00f3nica en el flujo sangu\u00edneo.<\/li>\n<\/ul>\n\n\n\n

    Voceros del gobierno japon\u00e9s, encabezados por el portavoz Minoru Kihara, destacaron la relevancia de este avance cient\u00edfico y se\u00f1alaron que la aprobaci\u00f3n se otorgar\u00e1 bajo un esquema condicional y de tiempo limitado. Asimismo, las autoridades sanitarias mantendr\u00e1n un monitoreo constante para verificar la seguridad y efectividad cl\u00ednica continua de los medicamentos tras su lanzamiento oficial en el mercado.<\/p>\n\n\n\n

    Con este paso hist\u00f3rico, Jap\u00f3n reafirma su liderazgo global en investigaci\u00f3n biom\u00e9dica y medicina regenerativa, ofreciendo una esperanza real a millones de pacientes alrededor del mundo.<\/p>\n","protected":false},"excerpt":{"rendered":"

    *Cient\u00edficos y autoridades sanitarias japonesas dan luz verde provisional a los primeros f\u00e1rmacos basados en c\u00e9lulas madre pluripotentes inducidas (iPS), abriendo una nueva era en la medicina regenerativa mundial. TOKIO \u2014 En un acontecimiento considerado un hito para la ciencia m\u00e9dica moderna, Jap\u00f3n se encuentra a un paso de consolidar la comercializaci\u00f3n de los primeros […]<\/p>\n","protected":false},"author":6,"featured_media":56979,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[],"class_list":["post-56978","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud"],"yoast_head":"\nHIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS -\" \/>\n<meta property=\"og:description\" content=\"*Cient\u00edficos y autoridades sanitarias japonesas dan luz verde provisional a los primeros f\u00e1rmacos basados en c\u00e9lulas madre pluripotentes inducidas (iPS), abriendo una nueva era en la medicina regenerativa mundial. TOKIO \u2014 En un acontecimiento considerado un hito para la ciencia m\u00e9dica moderna, Jap\u00f3n se encuentra a un paso de consolidar la comercializaci\u00f3n de los primeros […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-27T23:01:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-27T23:01:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/continuamosmx.com\/wp-content\/uploads\/2026\/07\/cel-1024x559.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"559\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Continuamos MX\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Continuamos MX\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/\"},\"author\":{\"name\":\"Continuamos MX\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#\\\/schema\\\/person\\\/5eb5356acb1fad784da407d14f0e8d89\"},\"headline\":\"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS\",\"datePublished\":\"2026-07-27T23:01:25+00:00\",\"dateModified\":\"2026-07-27T23:01:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/\"},\"wordCount\":309,\"publisher\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/continuamosmx.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/cel-scaled.png\",\"articleSection\":[\"SALUD\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/\",\"url\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/\",\"name\":\"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS -\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/continuamosmx.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/cel-scaled.png\",\"datePublished\":\"2026-07-27T23:01:25+00:00\",\"dateModified\":\"2026-07-27T23:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/#primaryimage\",\"url\":\"https:\\\/\\\/continuamosmx.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/cel-scaled.png\",\"contentUrl\":\"https:\\\/\\\/continuamosmx.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/cel-scaled.png\",\"width\":2560,\"height\":1396},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/2026\\\/07\\\/27\\\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/continuamosmx.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#website\",\"url\":\"https:\\\/\\\/continuamosmx.com\\\/\",\"name\":\"www.continuamosmx.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/continuamosmx.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#organization\",\"name\":\"ContinuamosMX\",\"url\":\"https:\\\/\\\/continuamosmx.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/continuamosmx.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cropped-LOGO-CONTI-NUEVO.png\",\"contentUrl\":\"https:\\\/\\\/continuamosmx.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cropped-LOGO-CONTI-NUEVO.png\",\"width\":1257,\"height\":430,\"caption\":\"ContinuamosMX\"},\"image\":{\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/continuamosmx.com\\\/#\\\/schema\\\/person\\\/5eb5356acb1fad784da407d14f0e8d89\",\"name\":\"Continuamos MX\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/30d4f9723476a15f4da34d35fb3501f08d2357016c76051c6a85c354c7489589?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/30d4f9723476a15f4da34d35fb3501f08d2357016c76051c6a85c354c7489589?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/30d4f9723476a15f4da34d35fb3501f08d2357016c76051c6a85c354c7489589?s=96&d=mm&r=g\",\"caption\":\"Continuamos MX\"},\"sameAs\":[\"http:\\\/\\\/www.continuamos.mx\"],\"url\":\"https:\\\/\\\/continuamosmx.com\\\/index.php\\\/author\\\/continuamos\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/","og_locale":"es_ES","og_type":"article","og_title":"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS -","og_description":"*Cient\u00edficos y autoridades sanitarias japonesas dan luz verde provisional a los primeros f\u00e1rmacos basados en c\u00e9lulas madre pluripotentes inducidas (iPS), abriendo una nueva era en la medicina regenerativa mundial. TOKIO \u2014 En un acontecimiento considerado un hito para la ciencia m\u00e9dica moderna, Jap\u00f3n se encuentra a un paso de consolidar la comercializaci\u00f3n de los primeros […]","og_url":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/","article_published_time":"2026-07-27T23:01:25+00:00","article_modified_time":"2026-07-27T23:01:26+00:00","og_image":[{"width":1024,"height":559,"url":"https:\/\/continuamosmx.com\/wp-content\/uploads\/2026\/07\/cel-1024x559.png","type":"image\/png"}],"author":"Continuamos MX","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Continuamos MX","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/#article","isPartOf":{"@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/"},"author":{"name":"Continuamos MX","@id":"https:\/\/continuamosmx.com\/#\/schema\/person\/5eb5356acb1fad784da407d14f0e8d89"},"headline":"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS","datePublished":"2026-07-27T23:01:25+00:00","dateModified":"2026-07-27T23:01:26+00:00","mainEntityOfPage":{"@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/"},"wordCount":309,"publisher":{"@id":"https:\/\/continuamosmx.com\/#organization"},"image":{"@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/#primaryimage"},"thumbnailUrl":"https:\/\/continuamosmx.com\/wp-content\/uploads\/2026\/07\/cel-scaled.png","articleSection":["SALUD"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/","url":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/","name":"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS -","isPartOf":{"@id":"https:\/\/continuamosmx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/#primaryimage"},"image":{"@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/#primaryimage"},"thumbnailUrl":"https:\/\/continuamosmx.com\/wp-content\/uploads\/2026\/07\/cel-scaled.png","datePublished":"2026-07-27T23:01:25+00:00","dateModified":"2026-07-27T23:01:26+00:00","breadcrumb":{"@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/#primaryimage","url":"https:\/\/continuamosmx.com\/wp-content\/uploads\/2026\/07\/cel-scaled.png","contentUrl":"https:\/\/continuamosmx.com\/wp-content\/uploads\/2026\/07\/cel-scaled.png","width":2560,"height":1396},{"@type":"BreadcrumbList","@id":"https:\/\/continuamosmx.com\/index.php\/2026\/07\/27\/historico-japon-aprueba-tratamientos-con-celulas-madre-para-combatir-el-parkinson-y-las-cardiopatias\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/continuamosmx.com\/"},{"@type":"ListItem","position":2,"name":"HIST\u00d3RICO: JAP\u00d3N APRUEBA TRATAMIENTOS CON C\u00c9LULAS MADRE PARA COMBATIR EL PARKINSON Y LAS CARDIOPAT\u00cdAS"}]},{"@type":"WebSite","@id":"https:\/\/continuamosmx.com\/#website","url":"https:\/\/continuamosmx.com\/","name":"www.continuamosmx.com","description":"","publisher":{"@id":"https:\/\/continuamosmx.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/continuamosmx.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/continuamosmx.com\/#organization","name":"ContinuamosMX","url":"https:\/\/continuamosmx.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/continuamosmx.com\/#\/schema\/logo\/image\/","url":"https:\/\/continuamosmx.com\/wp-content\/uploads\/2023\/04\/cropped-LOGO-CONTI-NUEVO.png","contentUrl":"https:\/\/continuamosmx.com\/wp-content\/uploads\/2023\/04\/cropped-LOGO-CONTI-NUEVO.png","width":1257,"height":430,"caption":"ContinuamosMX"},"image":{"@id":"https:\/\/continuamosmx.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/continuamosmx.com\/#\/schema\/person\/5eb5356acb1fad784da407d14f0e8d89","name":"Continuamos MX","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/30d4f9723476a15f4da34d35fb3501f08d2357016c76051c6a85c354c7489589?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/30d4f9723476a15f4da34d35fb3501f08d2357016c76051c6a85c354c7489589?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/30d4f9723476a15f4da34d35fb3501f08d2357016c76051c6a85c354c7489589?s=96&d=mm&r=g","caption":"Continuamos MX"},"sameAs":["http:\/\/www.continuamos.mx"],"url":"https:\/\/continuamosmx.com\/index.php\/author\/continuamos\/"}]}},"_links":{"self":[{"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/posts\/56978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/comments?post=56978"}],"version-history":[{"count":1,"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/posts\/56978\/revisions"}],"predecessor-version":[{"id":56980,"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/posts\/56978\/revisions\/56980"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/media\/56979"}],"wp:attachment":[{"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/media?parent=56978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/categories?post=56978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/continuamosmx.com\/index.php\/wp-json\/wp\/v2\/tags?post=56978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}